Literature DB >> 12477745

Is intestinal metaplasia of the stomach reversible?

M M Walker1.   

Abstract

Intestinal metaplasia (IM) of the stomach is a risk factor in developing intestinal-type gastric cancer and hence the question of reversibility is vital. There is emerging epidemiological evidence that with long term follow up, IM may be reversible although a combination of antioxidant agents and eradication of H pylori may be necessary to achieve this. The pathogenesis of IM is currently being elucidated and it is likely that a combination of bacterial, host, and environmental factors will be shown to lead to IM. In assessing gastric cancer risk, histochemical typing of IM will most probably be replaced by molecular markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477745      PMCID: PMC1773527          DOI: 10.1136/gut.52.1.1

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia.

Authors:  Akashi Eda; Hiroyuki Osawa; Ichiro Yanaka; Kiichi Satoh; Hiroyuki Mutoh; Ken Kihira; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

2.  Key molecules in metaplastic gastritis: sequential analysis of CDX1/2 homeobox gene expression.

Authors:  Tsutomu Chiba; Hiroshi Seno
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

3.  Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study.

Authors:  M Asaka; T Sugiyama; A Nobuta; M Kato; H Takeda; D Y Graham
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

4.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

5.  Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis.

Authors:  F Petersson; K Borch; L E Franzén
Journal:  Scand J Gastroenterol       Date:  2002-03       Impact factor: 2.423

6.  Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia.

Authors:  J Yu; W K Leung; E K Ng; K F To; M P Ebert; M Y Go; W Y Chan; F K Chan; S C Chung; P Malfertheiner; J J Sung
Journal:  Aliment Pharmacol Ther       Date:  2001-09       Impact factor: 8.171

7.  Genetic factors in the development of gastric precancerous lesions--a role of Helicobacter pylori ?

Authors:  M Jablonská; A Chlumská
Journal:  J Physiol Paris       Date:  2001 Jan-Dec

Review 8.  Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan.

Authors:  K Satoh
Journal:  Gastroenterol Clin North Am       Date:  2000-12       Impact factor: 3.806

9.  Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study.

Authors:  A Zullo; V Rinaldi; C Hassan; F Diana; S Winn; G Castagna; A F Attili
Journal:  Aliment Pharmacol Ther       Date:  2000-10       Impact factor: 8.171

10.  Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.

Authors:  W C You; L Zhang; M H Gail; Y S Chang; W D Liu; J L Ma; J Y Li; M L Jin; Y R Hu; C S Yang; M J Blaser; P Correa; W J Blot; J F Fraumeni; G W Xu
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

View more
  20 in total

1.  Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.

Authors:  Tetsuya Tsukamoto; Kenichi Inada; Harunari Tanaka; Tsutomu Mizoshita; Mami Mihara; Toshikazu Ushijima; Yoshitaka Yamamura; Shigeo Nakamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-04       Impact factor: 4.553

2.  Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer.

Authors:  Kentaro Sugano
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

Review 3.  Eradication of H pylori for the prevention of gastric cancer.

Authors:  Karolin Trautmann; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

4.  Bile acid increases expression of the histamine-producing enzyme, histidine decarboxylase, in gastric cells.

Authors:  Hye Jin Ku; Hye Young Kim; Hyeong Hoe Kim; Hee Ju Park; Jae Hun Cheong
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

5.  Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection.

Authors:  A Oksanen; A Sankila; K von Boguslawski; P Sipponen; H Rautelin
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 6.  Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA.

Authors:  Judy A Trieu; Mohammad Bilal; Hamzeh Saraireh; Andrew Y Wang
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

Review 7.  My approach to reporting a gastric biopsy.

Authors:  Carlos A Rubio
Journal:  J Clin Pathol       Date:  2006-09-08       Impact factor: 3.411

Review 8.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

9.  Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats.

Authors:  Xiao-Dong Zhu; Geng-Jin Lin; Li-Ping Qian; Zhong-Qing Chen
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.

Authors:  David H Wang; Anjana Tiwari; Monica E Kim; Nicholas J Clemons; Nanda L Regmi; William A Hodges; David M Berman; Elizabeth A Montgomery; D Neil Watkins; Xi Zhang; Qiuyang Zhang; Chunfa Jie; Stuart J Spechler; Rhonda F Souza
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.